Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about SLC2A1: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
SLC2A1 encodes GLUT1, the principal glucose transporter at the blood-brain barrier. Critical for brain energy metabolism, GLUT1 dysfunction contributes to Alzheimer's disease, Parkinson's disease, and GLUT1 deficiency syndrome. Essential for neuronal glucose uptake and metabolic homeostasis.
| Gene Symbol | SLC2A1 |
| Full Name | Solute Carrier Family 2 Member 1 (Glucose Transporter 1) |
| Chromosome | 1p34.2 |
| Protein Type | Transporter |
| Function | is a facilitative glucose transporter belonging to the SLC2A family that provides the critical link between systemic glucose supply and cerebral energy metabolism. |
| Molecular Weight | ~54 kDa |
| Amino Acids | 492 aa |
| Exons | 10 |
| Pathways | Ferroptosis, Mapk, Oxidative Stress, autophagy pathway, unfolded protein response |
| UniProt ID | P11166 |
| NCBI Gene ID | 6513 |
| Ensembl ID | ENSG00000117394 |
| OMIM | 138140 |
| GeneCards | SLC2A1 |
| Human Protein Atlas | SLC2A1 |
| Associated Diseases | Als, Ataxia, Cancer, Carcinoma, Infection, Ms |
| Interactions | COX4I1, GSK3B, IGF1, PPAR, MEF2C, NRF2 |
| KG Connections | 234 knowledge graph edges |
| Databases | GeneCardsHPASTRING |
Knowledge base pages for this entity
graph TD
SLC2A1["<b>SLC2A1</b>"]
GLUT1["GLUT1"]
SLC2A1 -->|"encodes"| GLUT1
Cancer{"Cancer"}
SLC2A1 -->|"inhibits"| Cancer
Tumor{"Tumor"}
SLC2A1 -->|"inhibits"| Tumor
Ms{"Ms"}
SLC2A1 -->|"therapeutic target"| Ms
SLC2A1 -->|"associated with"| Ms
Parkinson{"Parkinson"}
SLC2A1 -->|"associated with"| Parkinson
SLC2A1 -->|"associated with"| Cancer
SLC2A1 -->|"associated with"| Tumor
Carcinoma{"Carcinoma"}
SLC2A1 -->|"associated with"| Carcinoma
Oxidative_Phosphorylation(["Oxidative Phosphorylation"])
SLC2A1 -->|"inhibits"| Oxidative_Phosphorylation
Akt(["Akt"])
SLC2A1 -->|"interacts with"| Akt
Epigenetic(["Epigenetic"])
SLC2A1 -->|"associated with"| Epigenetic
CANCER["CANCER"]
CANCER -->|"inhibits"| SLC2A1
RB1["RB1"]
RB1 -->|"inhibits"| SLC2A1
PIK3CA["PIK3CA"]
PIK3CA -->|"interacts with"| SLC2A1
MMP9["MMP9"]
MMP9 -->|"interacts with"| SLC2A1
PPARA["PPARA"]
PPARA -->|"interacts with"| SLC2A1
IGF1R["IGF1R"]
IGF1R -->|"interacts with"| SLC2A1
RELA["RELA"]
RELA -->|"interacts with"| SLC2A1
AKT1["AKT1"]
AKT1 -->|"interacts with"| SLC2A1
INSR["INSR"]
INSR -->|"interacts with"| SLC2A1
TTR["TTR"]
TTR -->|"interacts with"| SLC2A1
PPARG["PPARG"]
PPARG -->|"interacts with"| SLC2A1
ESR1["ESR1"]
ESR1 -->|"interacts with"| SLC2A1
style SLC2A1 fill:#1a3a4a,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| glucose uptake | promotes | process | 0.90 |
| Glucose Transport | mediates | process | 0.85 |
| GLUT1 | encodes | protein | 0.70 |
| Cancer | inhibits | disease | 0.65 |
| Tumor | inhibits | disease | 0.65 |
| Ms | therapeutic_target | disease | 0.65 |
| Ms | associated_with | disease | 0.65 |
| Parkinson | associated_with | disease | 0.65 |
| Cancer | associated_with | disease | 0.65 |
| Tumor | associated_with | disease | 0.65 |
| Carcinoma | associated_with | disease | 0.65 |
| Neuroinflammation | protects_against | disease | 0.65 |
| Als | protects_against | disease | 0.65 |
| Neurodegeneration | protects_against | disease | 0.65 |
| Inflammation | protects_against | disease | 0.65 |
| Carcinoma | activates | disease | 0.65 |
| Cancer | activates | disease | 0.65 |
| Tumor | activates | disease | 0.65 |
| Als | associated_with | disease | 0.65 |
| Infection | associated_with | disease | 0.65 |
| Ataxia | associated_with | disease | 0.65 |
| Als | therapeutic_target | disease | 0.65 |
| Alzheimer | therapeutic_target | disease | 0.65 |
| Neuroinflammation | activates | disease | 0.65 |
| Neurodegeneration | activates | disease | 0.65 |
| Alzheimer | activates | disease | 0.65 |
| Aging | activates | disease | 0.65 |
| Inflammation | activates | disease | 0.65 |
| Ms | activates | disease | 0.65 |
| Diabetes | inhibits | disease | 0.65 |
| Fibrosis | inhibits | disease | 0.65 |
| Cardiovascular | inhibits | disease | 0.65 |
| ALS | protects_against | disease | 0.65 |
| Cardiomyopathy | inhibits | disease | 0.65 |
| COX4I1 | inhibits | gene | 0.60 |
| GSK3B | inhibits | gene | 0.60 |
| AKT | protects_against | gene | 0.60 |
| IGF1 | activates | gene | 0.60 |
| PPAR | activates | gene | 0.60 |
| MEF2C | activates | gene | 0.60 |
| NRF2 | activates | gene | 0.60 |
| NRXN3 | inhibits | gene | 0.60 |
| PRKAA1 | inhibits | gene | 0.60 |
| BDNF | inhibits | gene | 0.60 |
| SOD1 | inhibits | gene | 0.60 |
| NLGN2 | inhibits | gene | 0.60 |
| CYCS | inhibits | gene | 0.60 |
| PDHA1 | inhibits | gene | 0.60 |
| TXN | activates | gene | 0.60 |
| RAGE | associated_with | gene | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| AKT1 | phosphorylates | protein | 0.90 |
| HIF1A | upregulates | gene | 0.90 |
| PI3K/AKT | phosphorylates | pathway | 0.90 |
| AUTOPHAGY | regulates | phenotype | 0.65 |
| RB1 | inhibits | gene | 0.60 |
| PIK3CA | interacts_with | gene | 0.60 |
| MMP9 | interacts_with | gene | 0.60 |
| PPARA | interacts_with | gene | 0.60 |
| IGF1R | interacts_with | gene | 0.60 |
| RELA | interacts_with | gene | 0.60 |
| AKT1 | interacts_with | gene | 0.60 |
| TTR | interacts_with | gene | 0.60 |
| PPARG | interacts_with | gene | 0.60 |
| ESR1 | interacts_with | gene | 0.60 |
| MMP2 | interacts_with | gene | 0.60 |
| HIF1A | expressed_in | gene | 0.60 |
| HK2 | expressed_in | gene | 0.60 |
| ENO1 | associated_with | gene | 0.60 |
| NPM1 | associated_with | gene | 0.60 |
| HK2 | associated_with | gene | 0.60 |
| EGFR | associated_with | gene | 0.60 |
| NRXN3 | inhibits | gene | 0.60 |
| PDHA1 | inhibits | gene | 0.60 |
| BDNF | inhibits | gene | 0.60 |
| PRKAA1 | inhibits | gene | 0.60 |
| SOD2 | protects_against | gene | 0.60 |
| SOD1 | inhibits | gene | 0.60 |
| NLGN2 | inhibits | gene | 0.60 |
| PSD95 | protects_against | gene | 0.60 |
| CYCS | inhibits | gene | 0.60 |
| CAT | inhibits | gene | 0.60 |
| SLC2A2 | inhibits | gene | 0.60 |
| MYC | activates | gene | 0.60 |
| UBIQUITIN | activates | gene | 0.60 |
| ENO1 | activates | gene | 0.60 |
| CREB1 | activates | gene | 0.60 |
| NBN | associated_with | gene | 0.60 |
| TPX2 | associated_with | gene | 0.60 |
| ATM | associated_with | gene | 0.60 |
| MDC1 | associated_with | gene | 0.60 |
| ATR | associated_with | gene | 0.60 |
| MRE11 | associated_with | gene | 0.60 |
| SYN1 | associated_with | gene | 0.60 |
| CHEK1 | associated_with | gene | 0.60 |
| CHMP6 | associated_with | gene | 0.60 |
| EIF4EBP1 | associated_with | gene | 0.60 |
| PPARG | activates | gene | 0.60 |
| ERK1 | therapeutic_target | gene | 0.60 |
| PPARA | activates | gene | 0.60 |
| EGFR | activates | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||